Custom monoclonal antibodies are generated for non-therapeutic applications using the HuCAL technology. The HuCAL technology allows novel antibodies to be generated significantly faster than the...
For collaboration partners requiring fully human antibodies directed against their targets for further development as therapeutics, MorphoSys provides highly optimized antibodies according to its...
